Japanese encephalitis disease: overview of the virus, its risk to Australia and the need for better surveillance.

Intern Med J

Department of Microbiology, Queen Elizabeth II Medical Centre, PathWest Laboratory Medicine WA, Perth, Western Australia, Australia.

Published: December 2022

Download full-text PDF

Source
http://dx.doi.org/10.1111/imj.15967DOI Listing

Publication Analysis

Top Keywords

japanese encephalitis
4
encephalitis disease
4
disease overview
4
overview virus
4
virus risk
4
risk australia
4
australia better
4
better surveillance
4
japanese
1
disease
1

Similar Publications

[Viral-epigenetic hypothesis of Parkinson's disease etiopathogenesis.].

Adv Gerontol

January 2025

Bashkir State Medical University, 3 Lenin str., Ufa 450008, Russian Federation, e-mail:

Data accumulated in scientific literature indicate that Parkinson's disease develops after infections caused by SARS-CoV-2, West Nile, Coxsackie, St. Louis viruses, Japanese encephalitis B, hepatitis B and C, influenza A, HIV, herpes viruses, flaviviruses. Neuroinvasive West Nile viruses and HIV activate expression of alpha-synuclein.

View Article and Find Full Text PDF

Natural selection shapes codon usage and host adaptation of NS1 in mosquito-borne pathogenic flaviviruses.

Int J Biol Macromol

December 2024

National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China. Electronic address:

The NS1 protein of nine mosquito-borne flaviviruses, including Dengue virus 1-4, Japanese encephalitis virus, West Nile virus, Yellow fever virus, Tembusu virus, and Zika virus, shows distinct codon usage and evolutionary traits. Codon usage analysis shows notable base composition bias and non-conservatism in NS1, with distinct evolutionary traits from its ORF. Analysis of relative synonymous codon usage (RSCU) indicates that the NS1 genes exhibit non-conservative RSCU patterns within different mosquito-borne pathogenic flaviviruses.

View Article and Find Full Text PDF

Current epidemiology of infectious encephalitis: a narrative review.

Clin Microbiol Infect

December 2024

Department of Infectious Diseases, Aalborg University Hospital, 9000 Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, 9000 Aalborg, Denmark; European Society of Clinical Microbiology and Infectious Diseases Study Group of Infections of the Brain (ESGIB).

Background: Infectious encephalitis poses a global health challenge with a high mortality and severe neurological consequences in survivors. Emerging pathogens and outbreaks are reshaping the patterns of the disease.

Objective: To understand the current epidemiology for improving prevention, diagnosis, and treatment.

View Article and Find Full Text PDF

Flaviviruses, which include globally impactful pathogens, such as West Nile virus, yellow fever virus, Zika virus, Japanese encephalitis virus, and dengue virus, contribute significantly to human infections. Despite the ongoing emergence and resurgence of flavivirus-mediated pathogenesis, the absence of specific therapeutic options remains a challenge in the prevention and treatment of flaviviral infections. Through the intricate processes of fusion, transcription, replication, and maturation, the complex interplay of viral and host metabolic interactions affects pathophysiology.

View Article and Find Full Text PDF

Predicting the infecting dengue serotype from antibody titre data using machine learning.

PLoS Comput Biol

December 2024

MRC Centre for Global Infectious Disease Analysis and the Abdul Latif Jameel Institute for Disease and Emergency Analytics, School of Public Health, Imperial College London, London, United Kingdom.

The development of a safe and efficacious vaccine that provides immunity against all four dengue virus serotypes is a priority, and a significant challenge for vaccine development has been defining and measuring serotype-specific outcomes and correlates of protection. The plaque reduction neutralisation test (PRNT) is the gold standard assay for measuring serotype-specific antibodies, but this test cannot differentiate homotypic and heterotypic antibodies and characterising the infection history is challenging. To address this, we present an analysis of pre- and post-infection antibody titres measured using the PRNT, collected from a prospective cohort of Thai children.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!